GLP-1 Dose Calculator: What You'll Actually Pay Over 12 Months
The price you see for month 1 isn't the price you'll pay at month 12. Dose escalation, higher-dose premiums, and pricing tier changes make real annual cost significantly different from headline monthly rates. Here's the actual math.
The Verdict
Real 12-month GLP-1 cost ranges from ~$1,800 (oral Wegovy low dose) to ~$6,500 (retail branded injectable). Dose escalation adds 10â30% to headline monthly costs for compounded providers that charge by volume. Fixed-price providers (Yucca, Sprout price-lock) offer cost certainty. Understanding year-one vs. year-two vs. maintenance-phase pricing shapes which provider makes real economic sense.
When comparing GLP-1 pricing, most patients look at the headline monthly rate and multiply by 12. That math is wrong for most providers because it ignores dose titration. Over 12 months, patients typically climb through 4â6 dose levels, with pricing at many providers increasing at each dose step. The actual year-one cost can be 20â40% higher than the starter-dose price suggests.
Standard dose titration schedules
Semaglutide (Wegovy, Ozempic, compounded sema)
| Weeks | Dose | Typical Volume (compounded) |
|---|---|---|
| 1â4 | 0.25mg weekly | 0.05 mL from 5mg/mL vial |
| 5â8 | 0.5mg weekly | 0.10 mL |
| 9â12 | 1.0mg weekly | 0.20 mL |
| 13â16 | 1.7mg weekly | 0.34 mL |
| 17+ | 2.4mg weekly (maintenance) | 0.48 mL |
Tirzepatide (Mounjaro, Zepbound, compounded tirz)
| Weeks | Dose | Typical Volume |
|---|---|---|
| 1â4 | 2.5mg weekly | 0.5 mL from 5mg/mL vial |
| 5â8 | 5mg weekly | 1.0 mL |
| 9â12 | 7.5mg weekly | 1.5 mL |
| 13â16 | 10mg weekly | 2.0 mL |
| 17â20 | 12.5mg weekly | 2.5 mL |
| 21+ | 15mg weekly (maintenance) | 3.0 mL |
Many patients don't reach maximum doses â a significant portion stabilize at mid-range doses due to good response or side-effect tolerance. But for pricing calculation, assume maximum dose for a conservative annual cost estimate.
Year-one cost calculator by provider
Fixed-price compounded providers
Providers with flat pricing regardless of dose:
| Provider | Monthly Rate | 12-Month Total |
|---|---|---|
| Yucca Health (sema) | $146 | $1,752 |
| MEDVi (sema) | $179 (ongoing) | ~$2,050 (with $99 first month) |
| Sprout Health (sema) | $249 (ongoing, price-locked) | ~$2,938 (with $199 first month) |
| Care Bare Rx | $199 | $2,388 |
| Synergy Rx | $200 | $2,400 |
Note: "Price-locked" means the rate doesn't change as your dose increases. This is a meaningful advantage for patients titrating to higher doses.
Variable-price compounded providers
Some providers charge more at higher doses. For patients likely to reach high doses, this matters:
| Provider | Starter Dose Rate | High-Dose Rate | 12-Month Cost Range |
|---|---|---|---|
| SHED (varies by format) | $199 | $249â299 | $2,388â$3,388 |
| Various smaller providers | $149â179 | $249â349 | $2,200â$3,500 |
Brand-name injectable (FDA-approved)
| Option | Monthly Rate | 12-Month Total |
|---|---|---|
| Wegovy 12-mo subscription | $249 | $2,988 |
| Wegovy NovoCare cash | $349 | $4,188 |
| Zepbound 2.5mg vial | $299 (maintained if not titrating) | $3,588 |
| Zepbound 5mg vial | $399 | $4,788 |
| Zepbound 7.5mgâ15mg vial | $449 | $5,388 |
| Zepbound pen retail | ~$1,060 | ~$12,720 (not realistic) |
Realistic Zepbound year-one cost with titration
For Zepbound specifically, year-one cost varies significantly based on speed of titration:
- Months 1â2 at 2.5mg: $299 Ã 2 = $598
- Months 3â4 at 5mg: $399 Ã 2 = $798
- Months 5â12 at 7.5mg+: $449 Ã 8 = $3,592
- Total year 1: $4,988
Compared to Wegovy subscription at flat $249/mo ($2,988 annual), Zepbound is roughly $2,000 more expensive in year one for patients who titrate to higher doses.
Oral medications
| Option | Monthly Rate | 12-Month Total |
|---|---|---|
| Oral Wegovy 1.5mg (through Aug 2026) | $149 | $1,788 |
| Oral Wegovy 4mg (through Aug 2026) | $149 | $1,788 |
| Oral Wegovy 4mg (post-Aug 2026) | $199 | $2,388 |
| Oral Wegovy higher doses | $299 | $3,588 |
Insurance-covered pricing
| Scenario | Monthly Copay | 12-Month Total |
|---|---|---|
| Commercial insurance Wegovy + savings card | $0â$25 | $0â$300 |
| Commercial insurance Ozempic/Mounjaro | $25â$100 | $300â$1,200 |
| Medicare Part D 2026 | $50â$150 (tier-dependent) | $600â$1,800 |
| Medicare Part D 2027+ (negotiated) | $15â$50 | $180â$600 |
Year 2 (maintenance) cost differences
Year 2 often costs less than year 1 because:
- Many patients stabilize at mid-doses rather than maximum
- Some can drop to lower maintenance doses
- Promotional first-month discounts don't apply in year 2
- Some providers offer loyalty pricing to retain long-term patients
For stable maintenance:
- Compounded: $146â250/mo, little change
- Wegovy subscription: $249/mo, stable
- Zepbound: If maintained at lower dose, can drop to $299â399/mo
- Insurance-covered: Stable copays, potential PA renewal requirements
Total cost of GLP-1 treatment
Given the weight regain reality after discontinuation, most patients who start GLP-1s continue for years. For planning purposes:
| Duration | Yucca ($146/mo) | Wegovy Sub ($249/mo) | Insurance ($50/mo copay) |
|---|---|---|---|
| 1 year | $1,752 | $2,988 | $600 |
| 3 years | $5,256 | $8,964 | $1,800 |
| 5 years | $8,760 | $14,940 | $3,000 |
| 10 years | $17,520 | $29,880 | $6,000 |
These totals assume stable pricing, which historically hasn't held (prices have fallen). Actual totals over long horizons may be lower as GLP-1 pricing continues to decrease.
Hidden costs to factor
- Needles and syringes for vial-based products: ~$10â20/month if not provider-supplied
- Storage (small cooler for travel, medication fridge organization): ~$50â100 one-time
- Initial consultation fees for marketplace providers: $29â100 additional month 1
- Potential dose changes requiring additional consultations: ~$60/consultation
- Labs and monitoring: often covered by insurance separately but worth tracking
- Gym membership, trainer, nutritionist (optional but recommended): varies
Cost optimization strategy
- Check insurance first. Coverage usually beats all alternatives.
- Use HSA/FSA for effective 25â37% discount.
- For uninsured: Apply for manufacturer PAP before starting cash-pay.
- For self-pay: Consider price-locked providers (Sprout, Wegovy subscription) for predictability.
- Reassess annually. Market pricing changes; your optimal provider may change.
- Factor total cost, not monthly rate. Compare 12-month real costs across providers.
Bottom line
Real 12-month GLP-1 cost is often 10â30% higher than headline monthly pricing suggests due to dose titration. Fixed-price and price-locked providers (Yucca, Sprout, Wegovy subscription) offer cost predictability. Variable-dose providers (Zepbound vials, some compounded) can exceed expectations as you titrate up. Factor real year-one and year-two costs into provider decisions, not just starting prices. For long-term planning, assume multi-year treatment â total costs add up quickly at premium pricing.